Close
Back to VRNA Stock Lookup

(VRNA) – Hot FDA News

Dec 20, 2022 04:02 AM Verona Pharma (VRNA) Reports Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial
Jan 13, 2020 06:15 AM Verona Pharma (VRNA) 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy Met its Primary Endpoint
Nov 7, 2017 05:40 AM
Sep 27, 2017 05:47 AM
Sep 7, 2017 05:50 AM

Back to VRNA Stock Lookup